Table 5.
Multivariate subgroup analysis of 5-years OS, according to adjuvant chemotherapy and tumor sidedness.
| 5-years survival, % | HR | 95% CI | P | |
|---|---|---|---|---|
| Adjuvant chemotherapy (n = 8,985) | ||||
| Left sided | 73.4 | Ref = 1 | ||
| Right sided | 73.5 | 1.04 | 0.94–1.15 | 0.4623 |
| Transverse | 74.1 | 0.96 | 0.83–1.13 | 0.6022 |
| No adjuvant chemotherapy (n = 33,986) | ||||
| Left sided | 54 | Ref=1 | ||
| Right sided | 54.6 | 0.92 | 0.88–0.96 | <0.0001 |
| Transverse | 53.8 | 0.95 | 0.9–1.00 | 0.0677 |
| Left sided | ||||
| (n = 15,107) | ||||
| No chemotherapy | 54 | Ref = 1 | ||
| Chemotherapy | 73.4 | 0.58 | 0.53–0.62 | <0.0001 |
| Right sided | ||||
| (n = 23,151) | ||||
| No chemotherapy | 54.6 | Ref = 1 | ||
| Chemotherapy | 73.5 | 0.6 | 0.56–0.65 | <0.0001 |
| Transverse | ||||
| (n= 4,713) | ||||
| No chemotherapy | 53.8 | Ref = 1 | ||
| Chemotherapy | 74.1 | 0.55 | 0.48–0.64 | <0.0001 |